News

Juniper Pharma Services’ co-founder awarded CBE in the Queen’s New Year’s Honours List

Juniper Pharmaceuticals (Nasdaq:JNP), a diversified healthcare company focused on women’s health, today announced that Juniper Pharma Services co-founder Martyn Davies, ...
Read More
/ News

A bitter pill to swallow: challenges and advances in the development of medicines for children

Nottingham, UK – Juniper Pharma Services has confirmed a line-up of industry experts to speak at its Paediatrics seminar; ‘A ...
Read More
/ Events, News

Juniper Pharma Services and XenoGesis strengthen alliance in early drug development services

Nottingham, UK – Juniper Pharma Services and XenoGesis have extended their strategic alliance around their Enabling Technologies Rapid Screen through ...
Read More
/ News

Major Progress in Next Generation Medicines Initiative

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reached a key milestone in ...
Read More
/ News

Webinar – The Importance of Dose Prediction for Early Drug Development

Juniper Pharma Services will be presenting a webinar with Xenogesis: The Importance of Dose Prediction for Early Drug Development at 3.00pm (BST) ...
Read More
/ News

Juniper Pharma Services Brings PSD-1 Spray Dryer Online

Nottingham, UK – Juniper Pharma Services (“the company” or “Juniper”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has broadened ...
Read More
/ News

Juniper Pharma Services expands granulation capabilities

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has added a roller ...
Read More
/ News

Webinar – An Integrated Bio-Pharmaceutics Approach For Effective Drug Development

Juniper Pharma Services will be presenting a webinar with Xenogesis: An Integrated Bio-Pharmaceutics Approach for Effective Drug Development at 3.00pm – ...
Read More
/ News

Tablet press investment at Juniper Pharma Services

Nottingham, UK – Juniper Pharma Services (“the company”), a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has bolstered its tablet ...
Read More
/ News

Juniper Pharma Services strenghtens capsule capability with Xcelodose

Nottingham, UK – Juniper Pharma Services, a subsidiary of Juniper Pharmaceuticals, Inc. (Nasdaq: JNP), has reinforced its early stage capsule ...
Read More
/ News